The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO WCGIC 2020 | Baseline diffusion-weighted MRI to predict anal cancer recurrence
Kasia Owczarczyk
• 2 Jul 2020
Kasia Owczarczyk, MD, MRCP, FRCR, of King’s College London, London, UK, discusses how baseline diffusion-weighted magnetic resonance imaging (MRI) features can predict recurrence of anal squamous cell carcinoma following chemoradiotherapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
